HK1097855A1 - Method of detecting probnp with a monoclonal antibody binding to the amino acid 41-46 - Google Patents
Method of detecting probnp with a monoclonal antibody binding to the amino acid 41-46Info
- Publication number
- HK1097855A1 HK1097855A1 HK07102250.4A HK07102250A HK1097855A1 HK 1097855 A1 HK1097855 A1 HK 1097855A1 HK 07102250 A HK07102250 A HK 07102250A HK 1097855 A1 HK1097855 A1 HK 1097855A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- amino acid
- monoclonal antibody
- antibody binding
- probnp
- native probnp
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 150000001413 amino acids Chemical class 0.000 title 1
- 102100036836 Natriuretic peptides B Human genes 0.000 abstract 5
- 101710187802 Natriuretic peptides B Proteins 0.000 abstract 5
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 210000004408 hybridoma Anatomy 0.000 abstract 1
- 238000011895 specific detection Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Physics & Mathematics (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03010591 | 2003-05-12 | ||
| PCT/EP2004/005092 WO2004099253A1 (en) | 2003-05-12 | 2004-05-12 | Method of detecting probnp with a monoclonal antibody binding to the amino acid 41-46 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1097855A1 true HK1097855A1 (en) | 2007-07-06 |
Family
ID=33427054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK07102250.4A HK1097855A1 (en) | 2003-05-12 | 2007-02-28 | Method of detecting probnp with a monoclonal antibody binding to the amino acid 41-46 |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US7264939B2 (ko) |
| EP (4) | EP1625163B8 (ko) |
| JP (4) | JP4430066B2 (ko) |
| KR (2) | KR20080011467A (ko) |
| CN (3) | CN101967190A (ko) |
| AT (2) | ATE522546T1 (ko) |
| AU (1) | AU2004235974B2 (ko) |
| BR (1) | BRPI0410261B8 (ko) |
| CA (2) | CA2522378C (ko) |
| DK (3) | DK2256132T3 (ko) |
| ES (3) | ES2548327T3 (ko) |
| HK (1) | HK1097855A1 (ko) |
| HU (1) | HUE025169T2 (ko) |
| MX (1) | MXPA05011826A (ko) |
| PL (3) | PL1625163T3 (ko) |
| WO (2) | WO2004099253A1 (ko) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2843396B1 (fr) * | 2002-08-07 | 2005-04-15 | Bio Rad Pasteur | Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque |
| HUE025169T2 (en) * | 2003-05-12 | 2016-02-29 | Hoffmann La Roche | A method for detecting proBNP with a monoclonal antibody |
| WO2004105575A2 (en) * | 2003-05-29 | 2004-12-09 | Trustee Of Darmouth College | A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels |
| DE10355731A1 (de) | 2003-11-28 | 2005-06-30 | Roche Diagnostics Gmbh | Analytischer Sandwichtest zur Bestimmung von NT-proBNP |
| ATE364177T1 (de) * | 2004-07-07 | 2007-06-15 | Hoffmann La Roche | Kombinationen von markern zum nachweis von typ 1 und 2 diabetes |
| AT500800B1 (de) * | 2004-09-08 | 2008-07-15 | Biomedica Medizinprodukte Gmbh | Verfahren zur bestimmung von probnp |
| CN106908603B (zh) | 2007-01-25 | 2019-04-02 | 霍夫曼-拉罗奇有限公司 | Igfbp-7在心力衰竭评估中的用途 |
| KR100836322B1 (ko) * | 2007-08-31 | 2008-06-09 | 현대자동차주식회사 | 차량용 흡음재 제작장치 및 방법 |
| US9482677B2 (en) | 2008-02-27 | 2016-11-01 | Scios Inc. | Method, composition and device for sampling natriuretic peptides in a biological fluid |
| CA2722485C (en) | 2008-04-30 | 2018-02-13 | F. Hoffmann-La Roche Ag | Use of sfrp-3 in the assessment of heart failure |
| JP5592487B2 (ja) | 2009-07-27 | 2014-09-17 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 心不全の評価におけるミメカンの使用 |
| WO2011060361A1 (en) * | 2009-11-13 | 2011-05-19 | Bg Medicine, Inc. | Risk factors and prediction of myocardial infarction |
| CA2807240A1 (en) | 2010-08-04 | 2012-02-09 | Idexx Laboratories, Inc. | Detection of degradation products of canine nt-probnp |
| WO2012166918A1 (en) | 2011-05-31 | 2012-12-06 | Idexx Laboratories, Inc. | DETECTION OF DEGRADATION PRODUCTS OF FELINE NT-proBNP |
| WO2013042603A1 (ja) * | 2011-09-20 | 2013-03-28 | コニカミノルタホールディングス株式会社 | 検体希釈用液、それを用いたキットおよび蛍光測定方法 |
| US20140273273A1 (en) | 2012-11-01 | 2014-09-18 | Christie Mitchell Ballantyne | Biomarkers to improve prediction of heart failure risk |
| CN103304665A (zh) * | 2013-05-21 | 2013-09-18 | 上海贝西生物科技有限公司 | 一种抗氨基末端脑利钠肽前体单克隆抗体及其应用 |
| SG11201702490PA (en) * | 2014-10-10 | 2017-04-27 | Akira Matsumori | Method for detecting cardiac failure patient, method for discrimination of cardiac disease, test reagent for cardiac failure, test kit for cardiac failure, device for detecting cardiac failure, and program for detecting cardiac failure |
| EP3360570A1 (en) | 2017-02-13 | 2018-08-15 | Roche Diagnostics GmbH | Antibodies recognizing genetic variants |
| WO2019069885A1 (ja) * | 2017-10-02 | 2019-04-11 | コニカミノルタ株式会社 | アナライトの検出方法 |
| CN108752480B (zh) * | 2018-05-30 | 2022-03-29 | 中元汇吉生物技术股份有限公司 | 一种免疫原组合物、其制备方法及其用途 |
| US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
| US12001939B2 (en) | 2018-12-11 | 2024-06-04 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views |
| US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
| CN111487222B (zh) * | 2019-01-28 | 2023-11-14 | 上海乐合生物科技有限公司 | 一种检测bnp的spr芯片的制备方法 |
| JP2022544394A (ja) | 2019-08-13 | 2022-10-18 | ゲンティアン アクティーゼルスカブ | Ｎｔ－プロｂｎｐの定量のための高感度粒子増感アッセイ |
| WO2022069658A1 (en) | 2020-09-30 | 2022-04-07 | F. Hoffmann-La Roche Ag | Circulating total-nt-probnp (glycosylated and unglycosylated nt-probnp) and its ratio with nt-probnp (unglycosylated nt-probnp) in the assessment of atrial fibrillation |
| CN112986586A (zh) * | 2021-02-20 | 2021-06-18 | 广东菲鹏生物有限公司 | 一种氨基末端脑尿钠肽检测方法和试剂盒 |
| CN112964885B (zh) * | 2021-02-20 | 2022-11-11 | 广东菲鹏生物有限公司 | 一种氨基末端脑尿钠肽检测方法和试剂盒 |
| CN118119849A (zh) | 2021-10-01 | 2024-05-31 | 挪威金田有限公司 | 测定样品中N末端激素原BNP(NT-proBNP)浓度的新方法 |
| WO2023175152A1 (en) | 2022-03-18 | 2023-09-21 | Roche Diagnostics Gmbh | Troponin marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction |
| WO2023175176A1 (en) | 2022-03-18 | 2023-09-21 | Roche Diagnostics Gmbh | Cmybpc marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3445816C1 (de) | 1984-12-15 | 1986-06-12 | Behringwerke Ag, 3550 Marburg | Flaechenfoermiges diagnostisches Mittel |
| JP2665850B2 (ja) | 1991-11-14 | 1997-10-22 | 塩野義製薬株式会社 | ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体 |
| GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
| GB9827348D0 (en) * | 1998-12-12 | 1999-02-03 | Univ Leicester | Natriuretic peptide |
| IL144062A0 (en) | 1999-01-29 | 2002-04-21 | Roche Diagnostics Gmbh | METHOD OF IDENTIFYING N-TERMINAL proBNP |
| US20030219734A1 (en) | 2001-04-13 | 2003-11-27 | Biosite Incorporated | Polypeptides related to natriuretic peptides and methods of their identification and use |
| US20040096919A1 (en) * | 2002-11-18 | 2004-05-20 | Michelle Davey | Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP |
| HUE025169T2 (en) * | 2003-05-12 | 2016-02-29 | Hoffmann La Roche | A method for detecting proBNP with a monoclonal antibody |
-
2004
- 2004-05-12 HU HUE10172014A patent/HUE025169T2/en unknown
- 2004-05-12 JP JP2006505418A patent/JP4430066B2/ja not_active Expired - Lifetime
- 2004-05-12 AU AU2004235974A patent/AU2004235974B2/en not_active Expired
- 2004-05-12 DK DK10172014.2T patent/DK2256132T3/en active
- 2004-05-12 ES ES10172014.2T patent/ES2548327T3/es not_active Expired - Lifetime
- 2004-05-12 BR BRPI0410261A patent/BRPI0410261B8/pt active IP Right Grant
- 2004-05-12 DK DK04732282.1T patent/DK1625164T3/da active
- 2004-05-12 ES ES04732282T patent/ES2369008T3/es not_active Expired - Lifetime
- 2004-05-12 WO PCT/EP2004/005092 patent/WO2004099253A1/en active Search and Examination
- 2004-05-12 JP JP2006505419A patent/JP5128125B2/ja not_active Expired - Lifetime
- 2004-05-12 PL PL04732278T patent/PL1625163T3/pl unknown
- 2004-05-12 CN CN2010101190838A patent/CN101967190A/zh active Pending
- 2004-05-12 PL PL04732282T patent/PL1625164T3/pl unknown
- 2004-05-12 CA CA2522378A patent/CA2522378C/en not_active Expired - Lifetime
- 2004-05-12 ES ES04732278T patent/ES2372282T3/es not_active Expired - Lifetime
- 2004-05-12 AT AT04732278T patent/ATE522546T1/de active
- 2004-05-12 CN CNA2004800124973A patent/CN1784425A/zh active Pending
- 2004-05-12 EP EP04732278A patent/EP1625163B8/en not_active Expired - Lifetime
- 2004-05-12 MX MXPA05011826A patent/MXPA05011826A/es active IP Right Grant
- 2004-05-12 CN CNB200480012494XA patent/CN100497393C/zh not_active Expired - Lifetime
- 2004-05-12 EP EP04732282A patent/EP1625164B1/en not_active Expired - Lifetime
- 2004-05-12 AT AT04732282T patent/ATE517124T1/de active
- 2004-05-12 PL PL10172014T patent/PL2256132T3/pl unknown
- 2004-05-12 EP EP15161853.5A patent/EP2949669A1/en not_active Ceased
- 2004-05-12 CA CA2522747A patent/CA2522747C/en not_active Expired - Lifetime
- 2004-05-12 DK DK04732278.9T patent/DK1625163T3/da active
- 2004-05-12 KR KR1020087000782A patent/KR20080011467A/ko not_active Application Discontinuation
- 2004-05-12 WO PCT/EP2004/005091 patent/WO2004099252A1/en active Application Filing
- 2004-05-12 KR KR1020057021327A patent/KR100857752B1/ko active IP Right Grant
- 2004-05-12 EP EP10172014.2A patent/EP2256132B1/en not_active Expired - Lifetime
-
2005
- 2005-11-10 US US11/271,651 patent/US7264939B2/en not_active Expired - Lifetime
- 2005-11-10 US US11/271,138 patent/US7264938B2/en not_active Expired - Lifetime
-
2006
- 2006-12-05 US US11/634,286 patent/US7807380B2/en not_active Expired - Lifetime
- 2006-12-22 US US11/644,565 patent/US7811770B2/en not_active Expired - Lifetime
-
2007
- 2007-02-28 HK HK07102250.4A patent/HK1097855A1/xx not_active IP Right Cessation
-
2009
- 2009-09-04 JP JP2009204610A patent/JP4834136B2/ja not_active Expired - Lifetime
-
2012
- 2012-10-04 JP JP2012222436A patent/JP5649631B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1097855A1 (en) | Method of detecting probnp with a monoclonal antibody binding to the amino acid 41-46 | |
| HK1089232A1 (en) | Use of a midregional proadrenomedullin partial peptide in biological fluids in the production of immological diagnostic agents | |
| MX337991B (es) | Metodo para detectar cancer. | |
| ATE486093T1 (de) | Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt | |
| NZ603492A (en) | Humanized anti-factor d antibodies and uses thereof | |
| ATE440868T1 (de) | Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen | |
| EP2315034A3 (en) | Means and methods for assessing the risk of cardiac interventions based on GDF-15 | |
| DE602004001533D1 (de) | Immunotestverfahren für Herz-Troponin I | |
| DE60130852D1 (de) | Immuntest zur Messung des humanen C-Peptides sowie Reagenzienkit hierfür | |
| WO2009004822A1 (ja) | 抗Muc17抗体 | |
| IL212056A0 (en) | Monoclonal antibodies and methods for their use in the detection of cervical disease | |
| ATE335763T1 (de) | Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden | |
| WO2009075376A1 (ja) | 抗オフロキサシンモノクローナル抗体、これを用いたオフロキサシンの免疫学的測定方法 | |
| WO2008125733A8 (en) | Immunoassay for quantification of an unstable antigen selected from bnp and probnp | |
| WO2004110369A3 (en) | Cell surface protein associated with human chronic lymphocytic leukemia | |
| WO2009054091A1 (ja) | ガストリン放出ペプチド前駆体に対する抗体及びその使用 | |
| WO2008136510A1 (ja) | 自己免疫性膵炎及び劇症１型糖尿病の検査方法及び検査試薬 | |
| WO2003027149A1 (fr) | Anticorps et utilisation de ce dernier | |
| WO2012112013A3 (en) | A marker comprising anti-ck8/18 complex autoantibody and its use for diagnosing cancer | |
| WO2009044561A1 (ja) | 抗ｐｒｏＮＴ／ＮＭＮモノクローナル抗体 | |
| WO2009016734A1 (ja) | 軽度認知機能障害の検定方法 | |
| WO2009045075A3 (en) | A monoclonal antibody specific to human embryonic stem cell, a hybridoma secreting the same and a method for detecting or isolating non-differenced embryonic stem cell | |
| EP1359161A3 (en) | Monoclonal antibody specific to tartrate-resistant acid phosphatase 5b and use thereof | |
| ATE433109T1 (de) | Verfahren zur diagnose von tuberkulose | |
| WO2004029094B1 (en) | Monoclonal antibody specific for human mitochondrial adenylate kinase isozyme 3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |
Effective date: 20240511 |